Study to Evaluate the Effects of Renal Impairment on the Pharmacokinetics, Safety and Tolerability of GC4419
Clinical trial NCT05412472 · COMPLETED
Trial details
- NCT number
- NCT05412472
- Sponsor
- Galera Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-04
- Primary completion
- 2021-01-30
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.